Catalyst

Slingshot members are tracking this event:

Tesaro (TSRO) Plans to Report Phase 2 QUADRA Data in Q1 2018 Evaluating Niraparib in Ovarian Cancer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TSRO

100%

Additional Information

Additional Relevant Details Update on 27 february 2018: Initially expected in 2H 2017, it is now due for Q1 2018.
http://files.shareho...
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2, Quadra, Niraparib, Ovarian Cancer